Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
about
Antifungal Therapy in Hematopoietic Stem Cell Transplant RecipientsAntifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Breakthrough invasive candidiasis in patients on micafungin.Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysisPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.Echinocandin Resistance in Candida.Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin.Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.Antifungal chemoprophylaxis in children and adolescents with haematological malignancies and following allogeneic haematopoietic stem cell transplantation: review of the literature and options for clinical practice.Exserohilum infections: review of 48 cases before the 2012 United States outbreak.Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management.Mechanisms of echinocandin antifungal drug resistance.Echinocandins: The Expanding Antifungal Armamentarium.Comparison of Efficacy and Safety of Caspofungin Versus Micafungin in Pediatric Allogeneic Stem Cell Transplant Recipients: A Retrospective Analysis.Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.Eradication of pulmonary aspergillosis in an adolescent patient undergoing three allogeneic stem cell transplantations for acute lymphoblastic leukemia.Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies.Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp.Generation of resistance to amphotericin B and caspofungin in Candida spp.: experimental study.Current role of echinocandins in the management of invasive aspergillosis.Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins
P2860
Q28080147-2AB42321-E862-4C79-8E4B-EDD767B61795Q33559503-2E1379FA-DD01-4AB1-9C9B-3A1FC7BBFE8FQ33963538-83205E68-C617-45B1-8267-27A50490C099Q34322081-6BE25C56-ABE5-4128-A61E-CD02F20ECE72Q34532546-FC6A0CA4-E31F-40D6-AD1D-A1396EC1D646Q35959489-3E0D2F64-34D2-459A-AB86-63124F281140Q36276186-BED72F34-2D04-441F-8A06-CBC27B1D7481Q37220447-0B503F22-D0DB-42EA-8408-93DB61E2C21DQ37806065-E2EAA351-9B74-4445-9E01-F8051467AD74Q37993110-E3965530-8D83-44C9-8A63-1ACF7F0F1DCBQ38200494-FFB9CFC4-3245-4A5D-9F2A-009D6BA20507Q38254290-908B94E9-6018-4F8B-BB48-C4FCC8F54465Q38550402-418022A2-5A23-4A08-A5B7-8FEE899E520BQ38633102-90AFB231-0EBF-469E-B426-F8A901D634BCQ40060170-69EF1DC7-42C1-4DFC-8FE1-CED4595B3664Q40515140-AEA8274F-5596-4251-B62F-47265AF6B3EFQ41480974-DB3257BB-6701-4F71-8812-527617191865Q42038850-49FD8339-C962-4FC0-800B-90B04E50AC64Q43137240-B22CE4C9-D53C-4A90-B57D-3BCEBAFE1404Q43251096-0E2A8492-3038-478B-9137-497F16E94624Q45852198-7DD64A74-E2C4-4EAF-ACE1-CA3A76374363Q45923816-0CC35AB6-380C-4E16-8BC1-432627004B3EQ53217028-5C3F9679-C91F-4CB0-A39B-C1C6716B9E1CQ57746174-99E3E1B5-5B9D-4562-86AD-6289FD9BCF2D
P2860
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@en
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@nl
type
label
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@en
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@nl
prefLabel
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@en
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
@nl
P2093
P2860
P356
P1433
P1476
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients
@en
P2093
Cindy Ippoliti
Dimitrios P Kontoyiannis
Lillian S Chou
Richard E Champlin
P2860
P304
P356
10.1592/PHCO.27.12.1644
P407
P577
2007-12-01T00:00:00Z